Probiota Asia 2019

Watch – AB Biotics on why probiotics for cognitive health have huge potential in APAC

This content item was originally published on www.nutraingredients-asia.com, a William Reed online publication.

By Gary Scattergood

- Last updated on GMT

Related tags Probiota Nutrition P&g beauty business

AB Biotics has pledged to continue investing in clinical research to back-up the cognitive benefits of L. plantarum DR7 after acquiring the exclusive global licensing of the strain.

We spoke with the firm’s founder Miquel Bonachera at our recent Probiota Asia Summit in Singapore.

In this video, he explains the reasons for investing in the strain, which was discovered during a collaboration between Clinical Nutrition Sdn Bhd and University Sains Malaysia in 2014.

In addition to discussing the future research priorities and the latest understanding around the strain's mechanism of action, he also evaluates the business opportunities for new product development in the cognitive health space across a raft of life stages.

Watch the video for more.

Related news

Related products

show more

Prebiocran™, the new gut health solution

Prebiocran™, the new gut health solution

Content provided by Diana Food | 24-May-2023 | Research Study

Symrise is launching Prebiocran™, a 100% cranberry extract in powder designed to fit most of dietary supplement applications thanks to a low dosage: only...

Immune support for everyone

Immune support for everyone

Content provided by Kerry | 12-May-2023 | Infographic

Consumers of all ages cite immune health as a top benefit driving their purchases, along with improving gut/digestive health.

Metabolic Health Starts in the Gut Microbiome

Metabolic Health Starts in the Gut Microbiome

Content provided by ADM | 10-May-2023 | White Paper

Emerging clinical evidence suggests that BPL1™ Probiotic and BPL1™ Postbiotic may effectively support aspects of metabolic health.

Related suppliers

Follow us

Products

View more

Webinars